JP2002506617A - 軟骨肉腫関連遺伝子 - Google Patents

軟骨肉腫関連遺伝子

Info

Publication number
JP2002506617A
JP2002506617A JP2000535749A JP2000535749A JP2002506617A JP 2002506617 A JP2002506617 A JP 2002506617A JP 2000535749 A JP2000535749 A JP 2000535749A JP 2000535749 A JP2000535749 A JP 2000535749A JP 2002506617 A JP2002506617 A JP 2002506617A
Authority
JP
Japan
Prior art keywords
csa
polypeptide
expression
chondrosarcoma
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000535749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002506617A5 (https=
Inventor
リチャード エム． テレック，
Original Assignee
ロード アイランド ホスピタル， ア ライフスパン パートナー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ロード アイランド ホスピタル， ア ライフスパン パートナー filed Critical ロード アイランド ホスピタル， ア ライフスパン パートナー
Publication of JP2002506617A publication Critical patent/JP2002506617A/ja
Publication of JP2002506617A5 publication Critical patent/JP2002506617A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
JP2000535749A 1998-03-13 1999-03-12 軟骨肉腫関連遺伝子 Pending JP2002506617A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/042,225 1998-03-13
US09/042,225 US6207812B1 (en) 1998-03-13 1998-03-13 Chondrosarcoma associated genes
PCT/US1999/005348 WO1999046382A1 (en) 1998-03-13 1999-03-12 Chondrosarcoma associated genes

Publications (2)

Publication Number Publication Date
JP2002506617A true JP2002506617A (ja) 2002-03-05
JP2002506617A5 JP2002506617A5 (https=) 2006-04-27

Family

ID=21920744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000535749A Pending JP2002506617A (ja) 1998-03-13 1999-03-12 軟骨肉腫関連遺伝子

Country Status (11)

Country Link
US (2) US6207812B1 (https=)
EP (1) EP1062333B1 (https=)
JP (1) JP2002506617A (https=)
AT (1) ATE408686T1 (https=)
AU (1) AU762987B2 (https=)
CA (1) CA2323076A1 (https=)
DE (1) DE69939583D1 (https=)
DK (1) DK1062333T3 (https=)
ES (1) ES2317690T3 (https=)
PT (1) PT1062333E (https=)
WO (1) WO1999046382A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
KR102181548B1 (ko) * 2019-02-20 2020-11-20 한국외국어대학교 연구산학협력단 염증성 질환 또는 자가면역성 질환의 예방 또는 치료 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US5175385A (en) 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5350835A (en) * 1991-11-05 1994-09-27 Board Of Regents, University Of Texas Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
US5744343A (en) * 1994-01-04 1998-04-28 Mitotix, Inc. Ubiquitin conjugating enzymes
US5612455A (en) * 1994-07-05 1997-03-18 Tularik, Inc. Nuclear factors and binding assay

Also Published As

Publication number Publication date
US6207812B1 (en) 2001-03-27
AU762987B2 (en) 2003-07-10
DE69939583D1 (de) 2008-10-30
WO1999046382A1 (en) 1999-09-16
US20010016649A1 (en) 2001-08-23
AU2904099A (en) 1999-09-27
US7211646B2 (en) 2007-05-01
DK1062333T3 (da) 2009-01-26
ES2317690T3 (es) 2009-04-16
PT1062333E (pt) 2008-12-24
CA2323076A1 (en) 1999-09-16
EP1062333B1 (en) 2008-09-17
EP1062333A1 (en) 2000-12-27
ATE408686T1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
JP3981416B2 (ja) Ｐｃａ３タンパク質、ｐｃａ３遺伝子、及びこれらの用途
US6566063B1 (en) Methods for determining metastatic potential of breast cancer cells by detecting GSEF gene product expression
JP2003521878A (ja) 示差的遺伝子発現を使用して甲状腺癌を分類する方法
JPH11505322A (ja) Ｔｇｆ−ベータリセプター中の変異に基づく癌の診断および治療
EP0784703A1 (en) Laminin chains: diagnostic and therapeutic use
KR20060013425A (ko) 유방암의 확인, 평가, 예방 및 요법에 대한 조성물, 키트및 방법
JP2002505841A (ja) 低酸素調節性遺伝子
JP2002517244A (ja) 前立腺癌において示差的に調節される遺伝子および遺伝子発現産物
WO1999007893A1 (en) ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23
EP1690932A1 (en) Bone and/or joint disease-associated gene
JP2002525081A (ja) 低酸素により調節される遺伝子転写に特徴的な配列
JP2008154589A (ja) 結節性硬化症複合体関連障害の検出法および処置法
JP2002531061A (ja) 前立腺癌の診断および治療において有用な特異的核酸およびポリペプチドの発現解析
JP2002510208A (ja) 新規ステロイド受容体コアクチベーターａｉｂ１
US6361948B1 (en) Prognostic compositions for prostate cancer and methods of use thereof
US6833247B2 (en) Regulated prostate cancer genes
JP2002506617A (ja) 軟骨肉腫関連遺伝子
US20020081613A1 (en) Association of SIM2 with cancer
US7105315B2 (en) Transmembrane protein differentially expressed in cancer
WO2002029104A2 (en) Tumor marker and methods of use
US7883896B2 (en) Marker molecules associated with lung tumors
JP2003527831A (ja) エンドゼピン様ポリペプチドおよびエンドゼピン様ポリペプチドをコードするポリヌクレオチド
KR102575431B1 (ko) 골 질환의 예방 또는 치료를 위한 백스 인히비터-1의 용도
US20040127450A1 (en) Colon carcinoma related oligonucleotides and methods of use
JP2004201684A (ja) 乳癌の治療方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060308

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090515